Noticias de Eulerpool Beam Therapeutics

Beam Therapeutics Eulerpool-AFX

Beam Therapeutics Noticias de Acciones

Beam Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Beam Therapeutics.

• 4 de octubre ·

  TipRanks
  CRISPR Therapeutics Deserves its Lofty Valuation Even with Conservative Forecasts
• 29 de septiembre ·

  SeekingAlpha
  Beam Therapeutics: Still Holding Fast To Generous Valuation, Still Not A Buy
• 26 de septiembre ·

  Thefly.com
  Pfizer withdrawal of Oxbryta raises questions, sends Fulcrum stock higher
• 17 de septiembre ·

  TipRanks
  Hold Rating on Beam Therapeutics Amid Competitive Pressure and Absence of Clinical Data
• 17 de septiembre ·

  Thefly.com
  Beam Therapeutics initiated with neutral view at JonesResearch, here's why
• 11 de septiembre ·

  Thefly.com
  Krystal Biotech price target raised to $220 from $204 at Stifel
• 5 de septiembre ·

  Yahoo
  Why Is Beam Therapeutics (BEAM) Down 1.6% Since Last Earnings Report?
• 14 de agosto ·

  Yahoo
  Beam Therapeutics Inc. (BEAM): Pioneering Genetic Medicine with CRISPR Technology
• 14 de agosto ·

  TipRanks
  Analysts Are Bullish on Top Healthcare Stocks: Beam Therapeutics (BEAM), Taysha Gene Therapies (TSHA)
• 13 de agosto ·

  GuruFocus
  What's Driving Veracyte Inc's Surprising 39% Stock Rally?